Black Hawk Acquisition Corp
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
About Black Hawk Acquisition
Biological Products, (No Diagnostic Substances), SIC 2836
The company is a blank check entity established to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more operational businesses. It does not sell commercial products, manufacture goods, or provide traditional commercial services, and it does not serve standard retail or enterprise consumers. Instead, its sole operational endeavor consists of identifying, conducting due diligence on, and evaluating suitable acquisition target candidates seeking access to public capital markets, including pursuing a definitive business combination agreement with a therapeutics enterprise.
Incorporated as an exempted company with limited liability in the Cayman Islands, the organization maintains an international deal-sourcing scope without geographic restrictions on potential targets. Its management team operates from the United States with extensive networks spanning North America and global markets, though the filing does not report physical storefronts, operational facilities, or a specific corporate headquarters address.
Summary of the business section of Black Hawk Acquisition's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Black Hawk Acquisition Corp
- Founded
- 2023
- Headquarters
- Danville, CA
- Address
- 4125 Blackhawk Plaza Circle, Suite 166 94506
- Phone
- (203) 520-7122
- Employees
- 10, Nov 30, 2025
- Industry
- Biological Products, (No Diagnostic Substances)
- Fiscal year ends
- November 30
- Auditor
- MaloneBailey, LLP, Houston, Texas
Stock & identifiers
- Ticker
- BKHA
- Other tickers
- BKHAR, BKHAU
- Exchange
- Nasdaq
- IPO date
- Mar 22, 2024
- Shares outstanding
- 4M, Jul 15, 2026
- Public float
- $73.90M, May 31, 2025
- Filer category
- <br>Emerging growth company
- SEC CIK
- 2000775
- EIN
- 00-0000000
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
No recent ownership filings by officers or directors
Black Hawk Acquisition's leadership is listed in its proxy statement, last filed Jun 10, 2025.
Employees
Headcount reported in annual reports
“● our success in retaining or recruiting, or changes required in, our officers, key employees or directors following our initial business combination; … ● the other risk and uncertainties discussed in “Item 1A. Risk Factors,” elsewhere in this Annual Report on Form 10-K and in our other filings with the SEC.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Apr 14, 2026 | Late filing | Notification of late filing |
| Apr 1, 2026 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| Mar 2, 2026 | Late filing | Notification of late filing |
| Dec 23, 2025 | Merger | Registration of securities for a merger or exchange offer (S-4) |
| Oct 15, 2025 | Late filing | Notification of late filing |
| Mar 22, 2024 | IPO | Initial public offering priced (424B4 prospectus) |
| Mar 20, 2024 | Listing | Registration of securities on an exchange (Form 8-A) |